Table II.
Disease-free survival | Overall survival | |||||
---|---|---|---|---|---|---|
Multivariate analysis | Multivariate analysis | |||||
Clinicopathological characteristic | Univariate analysis P-value | P-value | 95.0% CI | Univariate analysis P-value | P-value | 95.0% CI |
Age | 0.598 | 0.352 | 0.516–1.516 | 0.809 | 0.539 | 0.534–1.534 |
Gender | 0.802 | 0.761 | 0.636–1.636 | 0.847 | 0.783 | 0.518–1.518 |
Tumor length | 0.665 | 0.947 | 0.614–1.614 | 0.617 | 0.935 | 0.621–1.621 |
Tumor differentiation | 0.095 | 0.512 | 0.803–1.803 | 0.280 | 0.812 | 0.741–1.741 |
Tumor invasion depth | 0.033 | 0.512 | 0.785–1.785 | 0.009 | 0.361 | 0.815–1.815 |
Lymph node metastasis stage | <0.001 | 0.031 | 1.035–2.035 | <0.001 | 0.020 | 1.070–2.070 |
Pathological tumor stage | <0.001 | 0.742 | 0.552–2.552 | <0.001 | 0.582 | 0.582–2.582 |
miR-1469 expression | 0.004 | 0.322 | 0.488–1.488 | 0.029 | 0.977 | 0.595–1.595 |
CI, confidence interval.